Overcome the challenges of PK assay development using TrailBlazer Antibodies
Thursday 7 October 2021
07:00 [PDT] 10:00 [EDT] 15:00 [BST]
Design and optimization of PK assays for large molecule biologics is complex and time consuming. Highly specific, well-characterized antibodies are critical for the optimization of selective and sensitive assays. TrailBlazer Antibodies are made using antibody phage display and a new, modular antibody assembly platform based on SpyTag technology. The in vitro method enables selection of inhibitory, noninhibitory and drug target complex-specific antibodies to address assay design for different modalities. SpyTag technology allows site-directed conjugation and rapid assembly of multiple bivalent and Ig-like formats. Discover how these technologies can benefit your PK assay development.
What will you learn?
- What SpyTag technology is and how it is incorporated into antibody phage display
- How site-directed conjugation and rapid assembly of antibody formats are achieved with SpyCatchers
- How TrailBlazer Antibodies can address the challenges of PK assay design, sensitivity and robustness
Who may this interest?
Scientists seeking custom antibody reagents to develop assays in support of the development of large molecule biologics, cell and gene therapies, vaccines and diagnostic tests.
Technical Sales Manager – Custom Antibodies
Bio-Rad Laboratories (UK)
Paul Royle is the Technical Sales Manager for Bio-Rad’s Custom Antibody Service and has been with Bio-Rad’s antibody division for over 7 years. Prior to this he worked in an immunology diagnostics company for almost 7 years. Paul holds a degree and PhD from the University of Nottingham (UK) and has postdoctoral research experience from the University of Warwick (UK).
In association with